SEC Form 4 · accession 0001471770-17-000007
DUPONT E I DE NEMOURS & CO · DD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas C Fanandakis
Officer — Executive Vice President & CFO
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000030554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2017 | D | 157,591 | — | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F2 | $49.9015 | Aug 31, 2017 | D | 49,487 | D | — | Feb 5, 2019 | Common Stock | 49,487 | 0 | D |
| Employee Stock Options (Right to Buy)F3 | $45.7189 | Aug 31, 2017 | D | 57,312 | D | — | Feb 5, 2020 | Common Stock | 57,312 | 0 | D |
| Employee Stock Options (Right to Buy)F4 | $59.6543 | Aug 31, 2017 | D | 47,407 | D | — | Feb 4, 2021 | Common Stock | 47,407 | 0 | D |
| Employee Stock Options (Right to Buy)F5 | $71.0648 | Aug 31, 2017 | D | 60,380 | D | — | Feb 3, 2022 | Common Stock | 60,380 | 0 | D |
| Employee Stock Options (Right to Buy)F6 | $58.76 | Aug 31, 2017 | D | 84,296 | D | — | Feb 2, 2026 | Common Stock | 84,296 | 0 | D |
| Employee Stock Options (Right to Buy)F7 | $76.17 | Aug 31, 2017 | D | 72,073 | D | — | Feb 1, 2027 | Common Stock | 72,073 | 0 | D |
Explanation of responses
- F1Disposed of pursuant to merger agreement between issuer and Dow Chemical Company in exchange for 202,028.8433 shares or stock units, as applicable, of DowDuPont common stock having a market value of $67.18 per share or stock unit, as applicable, on the effective date of the merger.
- F2This option, which provided for vesting in three equal annual installments beginning February 6, 2013, was assumed by DowDuPont in the merger and exchanged for 63,422 options at a grant price of $38.93.
- F3This option, which provided for vesting in three equal annual installments beginning February 6, 2014, was assumed by DowDuPont in the merger and exchanged for 73,473 options at a grant price of $35.67.
- F4This option, which provided for vesting in three equal annual installments beginning February 5, 2015, was assumed by DowDuPont in the merger and exchanged for 60,775 options at a grant price of $46.54.
- F5This option, which provided for vesting in three equal annual installments beginning February 4, 2016, was assumed by DowDuPont in the merger and exchanged for 77,407 options at a grant price of $55.44.
- F6This option, which provided for vesting in three equal annual installments beginning February 3, 2017, was assumed by DowDuPont in the merger and exchanged for 108,875 options at a grant price of $45.84.
- F7This option, which provided for vesting in three equal annual installments beginning February 2, 2018, was assumed by DowDuPont in the merger and exchanged for 92,397 options at a grant price of $59.42.